Group Wants Celebrex Advertisement to Stop

April 2007

Celebrex may cause heart attack or stroke Public Citizen, a consumer advocacy group, has gone to the Food and Drug Administration (FDA) to stop Pfizer from airing their new Celebrex television ad. The ad began last week after the FDA put a stop to them in 2004 over concerns the drug raised the risks of heart attacks and strokes.

Public Citizen claims the new Celebrex ad is misleading and plays down the cardiovascular and gastrointestinal risks of the drug. According to the FDA, Pfizer submitted the ad for review before putting it on the air. The FDA has told the consumer advocacy group that they will look into their claims and take the appropriate action.

Celebrex is the only Cox-2 inhibitor still on the U.S. market. Bextra and Vioxx were removed for the cardiovascular problems associated with them.

Think You Have a Case? Do You Need a Lawyer? How Much Does It Cost?	Related Links Dangerous Drug Information Dangerous Drugs Get FDA Approval Pfizer Revitalizes Celebrex's Ad Campaign Date Set for First Celebrex Trial Celebrex Gets Black Box Warning
Have you suffered injuries due to Celebrex? Contact us now for a FREE evaluation of your legal case.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: “FDA Is Asked to Halt Celebrex Ad.” By Jennifer Corbett Dooren. The Wall Street Journal. April 10, 2007.